Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen A Fletcher

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
The Journal of Infectious Diseases|November 26, 2013
Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combinationStephanie A Harris, Joel Meyer, Iman Satti, et al.
Ebiomedicine|February 13, 2016
Distinct Transcriptional and Anti-Mycobacterial Profiles of Peripheral Blood Monocytes Dependent on the Ratio of Monocytes: LymphocytesVivek Naranbhai, Helen A Fletcher, Rachel Tanner, et al.
Frontiers in Cellular and Infection Microbiology|September 28, 2020
Serum From Melioidosis Survivors Diminished Intracellular <i>Burkholderia pseudomallei</i> Growth in Macrophages: A Brief Research ReportPanjaporn Chaichana, Barbara Kronsteiner, Patpong Rongkard, et al.
Nature Medicine|October 27, 2004
Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humansHelen McShane, Ansar A Pathan, Clare R Sander, et al.
Vaccine|June 21, 2014
TRANSVAC workshop on standardisation and harmonisation of analytical platforms for HIV, TB and malaria vaccines: 'how can big data help?'Céline Dutruel, Jelle Thole, Mark Geels, et al.
Clinical and Vaccine Immunology : CVI|May 21, 2010
Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG-immunized adults vaccinated with a new tuberculosis vaccine, MVA85ASimone C de Cassan, Ansar A Pathan, Clare R Sander, et al.
Plos One|June 17, 2009
Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85AKathryn T Whelan, Ansar A Pathan, Clare R Sander, et al.
Biorxiv : the Preprint Server for Biology|July 1, 2024
Backtranslation of human RNA biosignatures of tuberculosis disease risk into the preclinical pipeline is condition dependentHannah Painter, Sasha E Larsen, Brittany D Williams, et al.
Msphere|December 9, 2024
Backtranslation of human RNA biosignatures of tuberculosis disease risk into the preclinical pipeline is condition dependentHannah Painter, Sasha E Larsen, Brittany D Williams, et al.
F1000Research|June 16, 2018
VALIDATE: Exploiting the synergy between complex intracellular pathogens to expedite vaccine research and development for tuberculosis, leishmaniasis, melioidosis and leprosyHelen A Fletcher, Mitali Chatterjee, Andrea Cooper, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
The Journal of Infectious Diseases|November 26, 2013
Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combinationStephanie A Harris, Joel Meyer, Iman Satti, et al.
Ebiomedicine|February 13, 2016
Distinct Transcriptional and Anti-Mycobacterial Profiles of Peripheral Blood Monocytes Dependent on the Ratio of Monocytes: LymphocytesVivek Naranbhai, Helen A Fletcher, Rachel Tanner, et al.
Frontiers in Cellular and Infection Microbiology|September 28, 2020
Serum From Melioidosis Survivors Diminished Intracellular <i>Burkholderia pseudomallei</i> Growth in Macrophages: A Brief Research ReportPanjaporn Chaichana, Barbara Kronsteiner, Patpong Rongkard, et al.
Nature Medicine|October 27, 2004
Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humansHelen McShane, Ansar A Pathan, Clare R Sander, et al.
Vaccine|June 21, 2014
TRANSVAC workshop on standardisation and harmonisation of analytical platforms for HIV, TB and malaria vaccines: 'how can big data help?'Céline Dutruel, Jelle Thole, Mark Geels, et al.
Clinical and Vaccine Immunology : CVI|May 21, 2010
Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG-immunized adults vaccinated with a new tuberculosis vaccine, MVA85ASimone C de Cassan, Ansar A Pathan, Clare R Sander, et al.
Plos One|June 17, 2009
Safety and immunogenicity of boosting BCG vaccinated subjects with BCG: comparison with boosting with a new TB vaccine, MVA85AKathryn T Whelan, Ansar A Pathan, Clare R Sander, et al.
Biorxiv : the Preprint Server for Biology|July 1, 2024
Backtranslation of human RNA biosignatures of tuberculosis disease risk into the preclinical pipeline is condition dependentHannah Painter, Sasha E Larsen, Brittany D Williams, et al.
Msphere|December 9, 2024
Backtranslation of human RNA biosignatures of tuberculosis disease risk into the preclinical pipeline is condition dependentHannah Painter, Sasha E Larsen, Brittany D Williams, et al.
F1000Research|June 16, 2018
VALIDATE: Exploiting the synergy between complex intracellular pathogens to expedite vaccine research and development for tuberculosis, leishmaniasis, melioidosis and leprosyHelen A Fletcher, Mitali Chatterjee, Andrea Cooper, et al.
Pageof 9